Drug & intervention

colchicine

RxCUI 2683

Clinical trials16
Recruiting2
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Colchicine

Colchicine, sold under the brand name Colbenemid among others, is a medication used to prevent and treat gout, to treat familial Mediterranean fever and Behçet's disease, and to reduce the risk of myocardial infarction. The American College of Rheumatology recommends colchicine, nonsteroidal anti-inflammatory drugs (NSAIDs) or steroids in the treatment of gout. Other uses for colchicine include the management of pericarditis. Colchicine is taken by mouth. The injectable route of administration for colchicine can be toxic. In 2008, the US Food and Drug Administration removed all injectable colchicine from the US market. Colchicine has a narrow therapeutic index, so overdosing is a significant risk. Common side effects of colchicine include gastrointestinal upset, particularly at high doses. Severe side effects may include pancytopenia (low blood cell counts) and rhabdomyolysis (damage to skeletal muscle), and the medication can be deadly in overdose. Whether colchicine is safe for use during pregnancy is unclear, but its use during breastfeeding appears to be safe. Colchicine works by decreasing inflammation via multiple mechanisms. Colchicine, in the form of autumn crocus (Colchicum autumnale) crude extract, was used as early as 1500 BC to treat joint swelling. It was approved for medical use in the United States in 1961. It is available as a generic medication. In 2023, it was the 215th most commonly prescribed medication in the United States, with more than 2 million prescriptions. Colchicine is used in plant breeding to induce polyploidy, in which the number of chromo...

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

16 shown
CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With ColchicineNCT06158698 · 2023-11-14
RECRUITING
COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 DiabetesNCT05633810 · 2022-12-21
RECRUITING
Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection FractionNCT06217120 · 2024-03-01
UNKNOWN
The COLchicine HEART Failure PRESERVED Trial (COLHEART-PRESERVED)NCT06081049 · 2024-01-18
UNKNOWN
Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection FractionNCT05637398 · 2022-12-15
COMPLETED
Colchicine in HFpEFNCT04857931 · 2022-06-17
TERMINATED
Colchicine to Suppress Inflammation and Improve Insulin Resistance in Adults and Adolescents With ObesityNCT05017571 · 2021-11-08
COMPLETED
The COlchicine HypERtENsion TrialNCT04916522 · 2021-08-10
ACTIVE_NOT_RECRUITING
COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial InfarctionNCT04420624 · 2020-12-04
TERMINATED
Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis.NCT04056039 · 2018-08-14
COMPLETED
Colchicine for Diabetic Nephropathy TrialNCT02442921 · 2016-02-22
UNKNOWN
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIVNCT02624180 · 2015-11-01
COMPLETED
Oral Colchicine in Men With Castrate Resistant Prostate CancerNCT01481233 · 2013-05-01
WITHDRAWN
Colchicine for Diabetic NephropathyNCT01005121 · 2009-12-01
UNKNOWN
Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.NCT00235079 · 2005-11-01
COMPLETED
Asthma Clinical Research Network (ACRN)NCT00000577 · 1993-09-01
WITHDRAWN

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.